The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and pathological prognostic factors in Merkel cell carcinoma.
 
Valeria Tovazzi
No Relationships to Disclose
 
Luigi Lorini
No Relationships to Disclose
 
Simonetta Battocchio
No Relationships to Disclose
 
Marina Zannoni
No Relationships to Disclose
 
Gaetano Paolino
No Relationships to Disclose
 
Sara Cingarlini
No Relationships to Disclose
 
Manuel Zamparini
No Relationships to Disclose
 
Michele Tomasoni
No Relationships to Disclose
 
Marco Ravanelli
No Relationships to Disclose
 
Arianna Oberti
No Relationships to Disclose
 
Alberto Grammatica
No Relationships to Disclose
 
Michela Buglione
No Relationships to Disclose
 
Stefano M. Magrini
No Relationships to Disclose
 
Roberto Maroldi
No Relationships to Disclose
 
Cesare Piazza
No Relationships to Disclose
 
Fabio Facchetti
No Relationships to Disclose
 
Aldo Scarpa
Consulting or Advisory Role - Incyte
Speakers' Bureau - Amgen; GlaxoSmithKline/Tesaro; MSD
 
Alfredo Berruti
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi; Sanofi
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD Oncology; Regeneron
Consulting or Advisory Role - Angelini Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD Oncology; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)